Clinical Trial Update: RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for RBM-007 in treatment-naïve exudative age-related macular degeneration has completed, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• RBM-007

Snippet

Sponsor: Maturi, Raj K., M.D., P.C. | Conditions: Age Related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-04-12